IDT Biologika

IDT Biologika is a global contract development and manufacturing organization (CDMO) supporting pharmaceutical and biotechnology companies in bringing innovative therapies to patients. Founded in 1921 and part of SK bioscience, the company draws on more than a century of vaccine experience and serves customers across the global biopharmaceutical industry.

Its integrated services span the product lifecycle, from development and technology transfer through clinical and commercial manufacturing. IDT Biologika works with vaccines, proteins, monoclonal antibodies, biosimilars, viral vectors, gene and immunotherapies, and other sterile injectable biologics. Development capabilities include cell-line, process and analytical development. Manufacturing services cover drug substance production, process platforms, aseptic filling and lyophilization, secondary packaging, quality control, analytics and regulatory support.

With facilities in Dessau-Roßlau and Magdeburg, including BSL-2 manufacturing capabilities, the company provides scalable production solutions, from clinical materials to industrial-scale supply. Its specialized teams and proprietary technologies help customers transfer processes, scale manufacturing and meet product and regulatory requirements. IDT Biologika combines scientific expertise, modern production technologies and quality-focused collaboration to deliver end-to-end biopharmaceutical manufacturing services.